CorMedix Inc. (CRMD)
CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates
Bone Biologics Corp (BBLG)
Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook
Ensysce Biosciences Inc. (ENSC)
Ensysce Biosciences Receives EU Patent Expanding its First-in-Class ADHD Therapy with Built-In Abuse and Overdose Protection
Humacyte Inc (HUMA)
Humacyte Announces Hospital Charge Data Showing High Expense of Preventable Extremity Arterial Injury Complications
Reviva Pharmaceuticals Holdings Inc. (RVPHW)
Reviva Announces Publication on Clinical Vocal Biomarker Data from the RECOVER Phase 3 Clinical Trial of Brilaroxazine to Treat Negative Symptoms in Schizophrenia
Korro Bio Inc (KRRO)
Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference
Humacyte Inc (HUMAW)
Humacyte Announces Hospital Charge Data Showing High Expense of Preventable Extremity Arterial Injury Complications
Emergent Biosolutions Inc. (EBS)
Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa
Xwell Inc (XWEL)
XWELL Reaffirms Commitment to Biosecurity, Appoints Former CDC Senior Advisor
Curaleaf Hldgs Inc. (CURLF)
Curaleaf Announces Proposed Domestication to Delaware